Healthcare Services company Inventurus Knowledge Solutions announced Q3FY25 results Revenue at Rs 6,572 million (15.9% YoY / + 2.2% QoQ growth). EBITDA at Rs 2,006 million at 30.5% of revenue (24.3% YoY / +5.7% QoQ growth). PAT at Rs 1,297 million at 19.7% of revenue (27.7% YoY / 14.8% QoQ growth). Adjusted PAT at Rs 1,455 million at 22.1% of revenue (30.6% YoY / 12.8% QoQ growth). Sachin K. Gupta, Founder and Chief Executive Officer, IKS Health, said: “We continue our journey of improving profitability by transforming legacy AQuity’s operating model through technology and global human capital. EBITDA margins have crossed 30% this quarter, a significant improvement from the 24% proforma margin of FY24. With revenue from our top five customers growing 19% and new client acquisitions ramping up, we are optimistic about sustained growth heading into the final quarter and the next financial year.” Nithya Balasubramanian, Chief Financial Officer, IKS Health, said: “We are steadily regaining our legacy IKS EBITDA margins. PAT growth has outpaced EBITDA growth due to lower finance costs as we continue to repay our debt. Adjusted PAT, excluding non-cash amortization of acquired intangibles, has improved by 31%. We will maintain our investments in technology and AI to drive superior outcomes and enhance customer satisfaction.” Result PDF
Conference Call with Inventurus Knowledge Solutions Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.